PocDoc granted multiple patents across Europe and the United States for its technology as the world’s first quantitative smartphone digital health check

PocDoc, the multi-award-winning health tech company, today announces it has been granted multiple patents in both the United States and Europe for their highly innovative technology in delivering a laboratory-equivalent clinical pathway, including multi-market quantitative blood tests in the cardiovascular disease prevention space.

In the fast growing health-tech market, PocDoc’s multiple patents will protect its innovative microfluidic assay technology (MFA), applied AI image analysis pipeline, HUESnap® and elements of their digital architecture integrations with healthcare systems, called PocDocOS®.

The company has multiple patents pending using their technology to focus on other disease areas, such as metabolic and renal diseases. The Healthy Heart Check alone is set to help detect and prevent cardiovascular disease in over 7.6 million individuals across the UK.

Steve Roest, PocDoc’s CEO and co-founder, said:

“Our vision is that in 10 years time, 150 million people will have been screened for their Cardio, Metabolic and Renal health using PocDoc technology and 30 million high-risk individuals will have been treated through our PocDoc platform. Our patented and patent-pending technology drives us on this mission to revolutionise preventive care methods globally and represents a massive leap forward in technical capability for the digital diagnostics industry”.

How does the Healthy Heart Check works:

• Cardiovascular is one of the leading causes of death in the UK

• Though it affects millions of people, 80% of cardiovascular disease cases can be prevented.

• PocDoc prioritises the early detection and prevention of diseases through a 10 minute Cardiovascular screening, including quantitative blood test and clinical risk assessment. 

• The Healthy Heart Check which is currently being rolled out across the NHS, Pharmacy and retail uses our patented MFA technology and HUESnap® to analyse the blood sample with a smart device and deliver the equivalent of the NHS Health Check in 10 minutes.

• The PocDoc App then breaks down the results, including the patient's complete cholesterol profile, healthy heart age, and 10-year risk of a heart attack or stroke, equivalent to the NHS health check.

In addition to the Healthy Heart Check patents, PocDoc's expansion into Metabolic and Renal disease diagnostic solutions has added incredible value to its IP portfolio.

About PocDoc:

PocDoc is a leading digital health platform that combines proprietary microfluidic tests and cloud-based AI diagnostics to deliver end-to-end digital pathways for cardiovascular disease assessment, diagnosis, and treatment. PocDoc aims to make diagnostic testing as accessible and affordable as possible.